These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3122788)

  • 1. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City.
    Marmor M; Des Jarlais DC; Cohen H; Friedman SR; Beatrice ST; Dubin N; el-Sadr W; Mildvan D; Yancovitz S; Mathur U
    AIDS; 1987 May; 1(1):39-44. PubMed ID: 3122788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection among intravenous drug users: epidemiology and risk reduction.
    Des Jarlais DC; Friedman SR
    AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
    Hartel DM; Schoenbaum EE
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge about AIDS and high-risk behavior among intravenous drug users in New York City.
    Selwyn PA; Feiner C; Cox CP; Lipshutz C; Cohen RL
    AIDS; 1987 Dec; 1(4):247-54. PubMed ID: 3126773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.
    Lamothe F; Bruneau J; Coates R; Rankin JG; Soto J; Arshinoff R; Brabant M; Vincelette J; Fauvel M
    CMAJ; 1993 Oct; 149(7):945-51. PubMed ID: 8402423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md.
    Nelson KE; Vlahov D; Solomon L; Cohn S; Muñoz A
    Arch Intern Med; 1995 Jun; 155(12):1305-11. PubMed ID: 7778962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus infection in a cohort of intravenous drug users in New York City. Demographic, behavioral, and clinical features.
    Brown LS; Chu A; Nemoto T; Ajuluchukwu D; Primm BJ
    N Y State J Med; 1989 Sep; 89(9):506-10. PubMed ID: 2797531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns.
    Friedland GH; Harris C; Butkus-Small C; Shine D; Moll B; Darrow W; Klein RS
    Arch Intern Med; 1985 Aug; 145(8):1413-7. PubMed ID: 3875327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acquired immunodeficiency syndrome and intravenous drug abuse.
    Battjes RJ; Leukefeld CG; Pickens RW; Haverkos HW
    Bull Narc; 1988; 40(1):21-34. PubMed ID: 3064841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Needle-sharing patterns as a predictor of HIV seroprevalence among New York City intravenous drug users (IVDUs).
    Yee K; Brown LS; Primm BJ; Nemoto T; Foster K
    NIDA Res Monogr; 1989; 95():488-9. PubMed ID: 2641040
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs.
    Marmor M; Titus S; Wolfe H; Krasinski K; Maslansky R; Simberkoff M; Beatrice S; Nichols S; Des Jarlais DC
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S207-13. PubMed ID: 7865302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
    Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.
    Maher L; Jalaludin B; Chant KG; Jayasuriya R; Sladden T; Kaldor JM; Sargent PL
    Addiction; 2006 Oct; 101(10):1499-508. PubMed ID: 16968352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md.
    Comer JA; Flynn C; Regnery RL; Vlahov D; Childs JE
    Arch Intern Med; 1996 Nov; 156(21):2491-5. PubMed ID: 8944742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors and predictors of human immunodeficiency virus infection among injection drug users.
    Backmund M; Meyer K; Henkel C; Reimer J; Wächtler M; Schütz CG
    Eur Addict Res; 2005; 11(3):138-44. PubMed ID: 15990431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
    AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Community-based survey on human immunodeficiency virus infection among injection drug users in Sichuan, China].
    Ruan YH; He YX; Xie LZ; Chen KL; Liu SZ; Zhou F; Qin GM; Shao YM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):296-9. PubMed ID: 15498238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV antibodies among intravenous drug users in Bahrain.
    al-Haddad MK; Khashaba AS; Baig BZ; Khalfan S
    J Commun Dis; 1994 Sep; 26(3):127-32. PubMed ID: 7868834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
    Guadagnino V; Zimatore G; Izzi A; Caroleo B; Rocca A; Montesano F; Costa C; Masciari R; Naso E; Biselli R
    J Clin Lab Immunol; 1995; 47(1):1-9. PubMed ID: 8735431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.